Supplementary Table S1 from UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Authors :: Matthew B. Soellner
Sofia D. Merajver
Kelley M. Kidwell
Carrie R. Graveel
Frank E. Kwarcinski
Michael E. Steffey
Kristoffer R. Brandvold
Michele L. Dziubinski
Eric J. Lachacz
Li Wei Bao
Sameer Phadke
Rabia A. Gilani
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Kinome-wide profiling data of UM-164 and dasatinib in MDA-MB 231 lysate

Full Text Access

Tools